Cardiovascular effects of (R)- and (S)-verapamil and racemic verapamil in humans: a placebo-controlled study

Stereoselective first‐pass metabolism of highly cleared drugs: studies of the bioavailability of L‐ and D‐verapamil examined with a stable isotope technique.

B. Vogelgesang, H Echizen, Elke Schmidt et al. · British Journal of Clinical Pharmacology · 1984 · 180 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Pharmacokinetics of (+)‐, (‐)‐ and (+/‐)‐verapamil after intravenous administration.

Michel Eichelbaum, Gerd Mikus, B. Vogelgesang · British Journal of Clinical Pharmacology · 1984 · 179 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +9

The effect of dextro-, levo-, and racemic verapamil on atrioventricular conduction in humans

Hirotoshi Echizen, Thomas Brecht, Sabine Niedergesäss et al. · American Heart Journal · 1985 · 135 citations

Medicine, Cardiology, Pharmacology +14

Ventricular control and exercise performance in chronic atrial fibrillation: Effects of diltiazem verapamil

Torbjörn Lundström, Lars Rydén · Journal of the American College of Cardiology · 1990 · 120 citations

Medicine, Cardiology, Pharmacology +17

Verapamil disposition kinetics in chronic atrial fibrillation

Robert E. Kates, Deborah Keefe, Janice B. Schwartz et al. · Clinical Pharmacology & Therapeutics · 1981 · 118 citations

Pharmacy, Pharmacokinetics, Pharmacology +15